ADMA Biologics
ADMA
#3463
Rank
โ‚น373.25 B
Marketcap
โ‚น1,564
Share price
-1.05%
Change (1 day)
8.60%
Change (1 year)

Market capitalization of ADMA Biologics (ADMA)

Market cap: โ‚น373.25 Billion

As of January 2026 ADMA Biologics has a market cap of โ‚น373.25 Billion. This makes ADMA Biologics the world's 3463th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ADMA Biologics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น373.25 B-9.63%
2025โ‚น413.01 B16.71%
2024โ‚น353.87 B316.18%
2023โ‚น85.02 B19.88%
2022โ‚น70.92 B245.13%
2021โ‚น20.55 B52.41%
2020โ‚น13.48 B-20.31%
2019โ‚น16.92 B118.44%
2018โ‚น7.74 B-16.6%
2017โ‚น9.28 B107.16%
2016โ‚น4.48 B-21.96%
2015โ‚น5.74 B-12.66%
2014โ‚น6.57 B46.91%
2013โ‚น4.47 B

End of Day market cap according to different sources

On Jan 16th, 2026 the market cap of ADMA Biologics was reported to be:

โ‚น372.26 Billion
by Nasdaq info icon info icon
โ‚น373.25 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novavax
NVAX
โ‚น117.61 B-68.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น824.11 B 120.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚น3.91 B-98.95%๐Ÿ‡บ๐Ÿ‡ธ USA